Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

(177)Lu: DDEP Evaluation of the decay scheme for an emerging radiopharmaceutical.

Kellett MA.

Appl Radiat Isot. 2016 Mar;109:129-32. doi: 10.1016/j.apradiso.2015.11.057. Epub 2015 Nov 23.

PMID:
26671793
2.

Morphological changes and clinical impact of unstable plaques within untreated segments of acute myocardial infarction patients during a 3-year follow-up: an analysis from the HORIZONS-AMI trial.

Souza CF, Doi H, Mintz GS, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie BR, Kellett MA Jr, Xu K, Mehran R, Stone GW, Maehara A.

Coron Artery Dis. 2015 Sep;26(6):469-75. doi: 10.1097/MCA.0000000000000251.

PMID:
25919902
3.

Reducing contrast-induced acute kidney injury using a regional multicenter quality improvement intervention.

Brown JR, Solomon RJ, Sarnak MJ, McCullough PA, Splaine ME, Davies L, Ross CS, Dauerman HL, Stender JL, Conley SM, Robb JF, Chaisson K, Boss R, Lambert P, Goldberg DJ, Lucier D, Fedele FA, Kellett MA, Horton S, Phillips WJ, Downs C, Wiseman A, MacKenzie TA, Malenka DJ; Northern New England Cardiovascular Disease Study Group..

Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):693-700. doi: 10.1161/CIRCOUTCOMES.114.000903. Epub 2014 Jul 29.

4.

(148g,m)Pm: evaluation of the decay schemes for two important reactor poisons.

Kellett MA, Bé MM.

Appl Radiat Isot. 2014 May;87:95-100. doi: 10.1016/j.apradiso.2013.11.009. Epub 2013 Nov 18.

PMID:
24296069
5.

Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial).

Yakushiji T, Inaba S, Maehara A, Brener SJ, Witzenbichler B, Guagliumi G, Brodie BR, Kellett MA Jr, Xu K, Mehran R, Mintz GS, Stone GW.

Am J Cardiol. 2013 Jun 1;111(11):1587-92. doi: 10.1016/j.amjcard.2013.01.329. Epub 2013 Mar 13.

PMID:
23497778
6.

Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial.

Tobbia P, Brodie BR, Witzenbichler B, Metzger C, Guagliumi G, Yu J, Kellett MA, Stuckey T, Fahy M, Mehran R, Stone GW.

EuroIntervention. 2013 Feb 22;8(10):1134-42. doi: 10.4244/EIJV8I10A176.

7.

Assessment of actinide decay data evaluations: findings of an IAEA Coordinated Research Project.

Kellett MA.

Appl Radiat Isot. 2012 Sep;70(9):1919-23. doi: 10.1016/j.apradiso.2012.02.036. Epub 2012 Feb 27.

PMID:
22425418
8.

Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy).

Choi SY, Maehara A, Cristea E, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Lansky AJ, Parise H, Mehran R, Mintz GS, Stone GW.

Am J Cardiol. 2012 Feb 15;109(4):455-60. doi: 10.1016/j.amjcard.2011.10.005. Epub 2011 Nov 24.

PMID:
22118823
9.

How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative.

Brown JR, McCullough PA, Splaine ME, Davies L, Ross CS, Dauerman HL, Robb JF, Boss R, Goldberg DJ, Fedele FA, Kellett MA, Phillips WJ, Ver Lee PN, Nelson EC, MacKenzie TA, O'Connor GT, Sarnak MJ, Malenka DJ; Northern New England Cardiovascular Disease Study Group..

BMJ Qual Saf. 2012 Jan;21(1):54-62. doi: 10.1136/bmjqs-2011-000041. Epub 2011 Sep 2.

10.

Extended Outcomes of Complex Coronary Disease in the Drug Eluting Stent Era.

Desrosiers KP, Brown JR, Langner CA, Sidhu MS, Robb JF, Hearne MJ, Lee PM, Kellett MA, Ryan TJ Jr, O'Meara JR, Dauerman HL, Silver MT, Thompson CA, Malenka DJ.

Cardiol Res. 2011 Jun;2(3):97-105. doi: 10.4021/cr38w. Epub 2011 May 20.

11.

The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

Wu X, Mintz GS, Xu K, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Stone GW, Maehara A.

JACC Cardiovasc Interv. 2011 May;4(5):495-502. doi: 10.1016/j.jcin.2010.12.012.

12.

Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy.

Choi SY, Witzenbichler B, Maehara A, Lansky AJ, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Dangas GD, Mintz GS, Stone GW.

Circ Cardiovasc Interv. 2011 Jun;4(3):239-47. doi: 10.1161/CIRCINTERVENTIONS.110.959791. Epub 2011 May 17.

13.

A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial.

Cannon LA, Kereiakes DJ, Mann T, Popma JJ, Mooney MR, Mishkel GJ, Lee TC, Wilson BH, Stuckey TD, Orlow S, McGarry T, Ring ME, Kellett MA, Underwood P, Dawkins KD.

EuroIntervention. 2011 Mar;6(8):920-7, 1-2. doi: 10.4244/EIJV6I8A161.

14.

Same admission cardiac catheterization and cardiac surgery: is there an increased incidence of acute kidney injury?

Kramer RS, Quinn RD, Groom RC, Braxton JH, Malenka DJ, Kellett MA, Brown JR; Northern New England Cardiovascular Disease Study Group..

Ann Thorac Surg. 2010 Nov;90(5):1418-23; discussion 1423-4. doi: 10.1016/j.athoracsur.2010.04.029.

PMID:
20971232
15.

Intravascular ultrasound findings of stent fractures in patients with Sirolimus- and Paclitaxel-eluting stents.

Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Parise H, Mehran R, Leon MB, Moses JW, Stone GW.

Am J Cardiol. 2010 Oct 1;106(7):952-7. doi: 10.1016/j.amjcard.2010.05.024. Epub 2010 Aug 11.

PMID:
20854956
16.

Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.

Guo N, Maehara A, Mintz GS, He Y, Xu K, Wu X, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Stone GW.

Circulation. 2010 Sep 14;122(11):1077-84. doi: 10.1161/CIRCULATIONAHA.109.906040. Epub 2010 Aug 30.

17.

Measurements of X- and γ-ray emission probabilities in the β(-) decay of (233)Pa.

Kondev FG, Ahmad I, Greene JP, Kellett MA, Nichols AL.

Appl Radiat Isot. 2010 Dec;68(12):2382-6. doi: 10.1016/j.apradiso.2010.06.009. Epub 2010 Jun 10.

PMID:
20594865
18.

Serial intravascular ultrasound analysis of the impact of myocardial bridge on neointimal proliferation after coronary stenting in patients with acute myocardial infarction.

Tsujita K, Maehara A, Mintz GS, Lansky AJ, Kubo T, Doi H, Yang J, Bharaj H, Witzenbichler B, Guagliumi G, Brodie BR, Kellett MA Jr, Parise H, Mehran R, Stone GW.

J Interv Cardiol. 2010 Apr;23(2):114-22. doi: 10.1111/j.1540-8183.2010.00531.x. Epub 2010 Mar 2.

PMID:
20236216
19.

Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.

Banning AP, Westaby S, Morice MC, Kappetein AP, Mohr FW, Berti S, Glauber M, Kellett MA, Kramer RS, Leadley K, Dawkins KD, Serruys PW.

J Am Coll Cardiol. 2010 Mar 16;55(11):1067-75. doi: 10.1016/j.jacc.2009.09.057. Epub 2010 Jan 14.

20.

Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy.

Maehara A, Mintz GS, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Parise H, Mehran R, Stone GW.

Circulation. 2009 Nov 10;120(19):1875-82. doi: 10.1161/CIRCULATIONAHA.109.873893. Epub 2009 Oct 26.

Supplemental Content

Loading ...
Support Center